Winthrop Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2K Hold
3
﹤0.01% 289
2026
Q1
$1K Hold
3
﹤0.01% 326
2025
Q4
$2K Sell
3
-1
-25% -$568 ﹤0.01% 292
2025
Q3
$2K Hold
4
﹤0.01% 263
2025
Q2
$1K Hold
4
﹤0.01% 312
2025
Q1
$1K Buy
4
+1
+33% +$336 ﹤0.01% 289
2024
Q4
$1K Sell
3
-1
-25% -$339 ﹤0.01% 301
2024
Q3
$1K Hold
4
﹤0.01% 147
2024
Q2
$2K Hold
4
﹤0.01% 123
2024
Q1
$2K Buy
+4
New +$1.41K ﹤0.01% 129

Other funds holding MEDP

Winthrop Capital Management's MEDP Position: Q2 2026 in Review

Winthrop Capital Management held its Medpace (MEDP) position steady in Q2 2026 at 3 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #289.

Winthrop Capital Management first reported a position in MEDP in Q1 2024 and has held it in 10 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Winthrop Capital Management held 3 shares of Medpace worth $2K as of Q2 2026.
  • Winthrop Capital Management left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Winthrop Capital Management's portfolio in Q2 2026, its #289 holding.
  • Winthrop Capital Management first reported a position in Medpace in Q1 2024 and has held it in 10 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.